Last reviewed · How we verify
High Dose Trivalent Inactivated Influenza Vaccine
High Dose Trivalent Inactivated Influenza Vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company. It is currently FDA-approved. Also known as: Fluzone® High Dose.
At a glance
| Generic name | High Dose Trivalent Inactivated Influenza Vaccine |
|---|---|
| Also known as | Fluzone® High Dose |
| Sponsor | Sanofi Pasteur, a Sanofi Company |
| Modality | Biologic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Influenza Vaccination Strategy for Patients With Hematologic Malignancy (PHASE3)
- Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age (PHASE3)
- High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater) (PHASE2)
- Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients (NA)
- Effects of Aging on Primary and Secondary Vaccine Responses (PHASE1)
- High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients (PHASE2)
- Standard Versus High Dose Inactivated Influenza Vaccine in RA (PHASE4)
- Standard-dose Versus High-dose Flu Vaccine in Solid Organ Transplant. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- High Dose Trivalent Inactivated Influenza Vaccine CI brief — competitive landscape report
- High Dose Trivalent Inactivated Influenza Vaccine updates RSS · CI watch RSS
- Sanofi Pasteur, a Sanofi Company portfolio CI
Frequently asked questions about High Dose Trivalent Inactivated Influenza Vaccine
What is High Dose Trivalent Inactivated Influenza Vaccine?
High Dose Trivalent Inactivated Influenza Vaccine is a Biologic drug developed by Sanofi Pasteur, a Sanofi Company.
Who makes High Dose Trivalent Inactivated Influenza Vaccine?
High Dose Trivalent Inactivated Influenza Vaccine is developed and marketed by Sanofi Pasteur, a Sanofi Company (see full Sanofi Pasteur, a Sanofi Company pipeline at /company/sanofi).
Is High Dose Trivalent Inactivated Influenza Vaccine also known as anything else?
High Dose Trivalent Inactivated Influenza Vaccine is also known as Fluzone® High Dose.
What development phase is High Dose Trivalent Inactivated Influenza Vaccine in?
High Dose Trivalent Inactivated Influenza Vaccine is FDA-approved (marketed).
Related
- Manufacturer: Sanofi Pasteur, a Sanofi Company — full pipeline
- Also known as: Fluzone® High Dose
- Compare: High Dose Trivalent Inactivated Influenza Vaccine vs similar drugs
- Pricing: High Dose Trivalent Inactivated Influenza Vaccine cost, discount & access